Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005

Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005–2020)

Published:2023-04-01 Issue:4 Volume:23 Page:172-194
ISSN:1530-3667
Container-title:Vector-Borne and Zoonotic Diseases
language:en
Short-container-title:Vector-Borne and Zoonotic Diseases

Author:

Burn Leah¹,Vyse Andrew²,Pilz Andreas³,Tran Thao Mai Phuong⁴,Fletcher Mark A.⁵,Angulo Frederick J.⁶,Gessner Bradford D.⁶,Moïsi Jennifer C.⁷,Stark James H.⁶^ORCID

Affiliation:

1. P95 Pharmacovigilance and Epidemiology, Princeton, New Jersey, USA.

2. Pfizer Vaccines Medical, Walton Oaks, United Kingdom.

3. Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.

4. P95 Pharmacovigilance and Epidemiology, Leuven, Belgium.

5. Pfizer Emerging Markets Medical Affairs, Vaccines, Paris, France.

6. Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, Pennsylvania, USA.

7. Pfizer Medical Development, Scientific and Clinical Affairs, Vaccines, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Infectious Diseases,Microbiology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0070

Reference71 articles.

2. Diagnostic challenges of early Lyme disease: Lessons from a community case series

3. Borrelia burgdorferi protein interactions critical for microbial persistence in mammals

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serological Assessment of Lyme borreliosis in Bulgaria: A Nationwide Study;Pathogens;2024-09-02

2. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies;The Lancet Infectious Diseases;2024-09

3. Vaccination hesistancy in Lyme borreliosis;The Lancet Infectious Diseases;2024-09

4. Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial;The Lancet Infectious Diseases;2024-07

5. Distribution and pathogen prevalence of field-collected ticks from south-western Korea: a study from 2019 to 2022;Scientific Reports;2024-05-29